| Literature DB >> 15098607 |
Hiroshi Ohnishi1, Masahiro Abe, Akihito Yokoyama, Hironobu Hamada, Ryoji Ito, Takeru Hirayama, Kazutaka Nishimura, Jitsuo Higaki.
Abstract
Clarithromycin (CAM) has been widely used for the treatment of respiratory infection. Macrolides are generally well tolerated and their adverse reactions are rare. An 80-year-old woman with nontuberculous mycobacterium infection was treated with combined chemotherapy, including isoniazid, rifampicin, and ethambutol. She developed a fever and peripheral blood eosinophilia, and new subpleural consolidations were observed on chest radiography three days after add-on therapy with CAM. The symptoms and clinical findings improved with the withdrawal of CAM. Histopathologic examinations confirmed the diagnosis of eosinophilic pneumonia. This is the first report of CAM-induced eosinophilic pneumonia.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15098607 DOI: 10.2169/internalmedicine.43.231
Source DB: PubMed Journal: Intern Med ISSN: 0918-2918 Impact factor: 1.271